Cited by 41Genetic factors in colorectal cancerColorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Regulator of Chromosome Condensation 2 Identifies High-Risk Patients within Both Major Phenotypes of Colorectal Cancer

Open access

Published version of a preprint

Abstract

Purpose: Colorectal cancer has high incidence and mortality worldwide. Patients with microsatellite instable (MSI) tumors have significantly better prognosis than patients with microsatellite stable (MSS) tumors. Considerable variation in disease outcome remains a challenge within each subgroup, and our purpose was to identify biomarkers that improve prediction of colorectal cancer prognosis. Experimental Design: Mutation analyses of 42 MSI target genes were performed in two independent MSI tumor series (n = 209). Markers that were significantly associated with prognosis in the test series were assessed in the validation series, followed by functional and genetic explorations. The clinical potential was further investigated by immunohistochemistry in a population-based colorectal cancer series (n = 903). Results: We identified the cell-cycle gene regulator of chromosome condensation 2 (RCC2) as a cancer biomarker. We found a mutation in the 5′ UTR region of RCC2 that in univariate and multivariate analyses was significantly associated with improved outcome in the MSI group. This mutation caused reduction of protein expression in dual luciferase gene reporter assays. siRNA knockdown in MSI colon cancer cells (HCT15) caused reduced cell proliferation, cell-cycle arrest, and increased apoptosis. Massive parallel sequencing revealed few RCC2 mutations in MSS tumors. However, weak RCC2 protein expression was significantly associated with poor prognosis, independent of clinical high-risk parameters, and stratifies clinically important patient subgroups with MSS tumors, including elderly patients (>75 years), stage II patients, and those with rectal cancer. Conclusions: Impaired RCC2 affects functional and clinical endpoints of colorectal cancer. High-risk patients with either MSI or MSS tumors can be identified with cost-effective routine RCC2 assays. Clin Cancer Res; 21(16); 3759–70. ©2015 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-14-3294

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 31

  1. Sinicrope, 2012, Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications, Clin Cancer Res, 18, 1506, 10.1158/1078-0432.CCR-11-1469 · DOI
  2. Lothe, 1993, Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history, Cancer Res, 53, 5849
  3. Thibodeau, 1993, Microsatellite instability in cancer of the proximal colon, Science, 260, 816, 10.1126/science.8484122 · DOI
  4. Popat, 2005, Systematic review of microsatellite instability and colorectal cancer prognosis, J Clin Oncol, 23, 609, 10.1200/JCO.2005.01.086 · DOI
  5. Duffy, 2014, Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers (EGTM) 2014 guidelines update, Int J Cancer, 134, 2513, 10.1002/ijc.28384 · DOI
  6. Royrvik, 2007, Slip slidin' away: a duodecennial review of targeted genes in mismatch repair deficient colorectal cancer, Crit Rev Oncog, 13, 229, 10.1615/CritRevOncog.v13.i3.20 · DOI
  7. Kim, 2002, Identification of MARCKS, FLJ11383 and TAF1B as putative novel target genes in colorectal carcinomas with microsatellite instability, Oncogene, 21, 5081, 10.1038/sj.onc.1205703 · DOI
  8. Mollinari, 2003, The mammalian passenger protein TD-60 is an RCC1 family member with an essential role in prometaphase to metaphase progression, Dev Cell, 5, 295, 10.1016/S1534-5807(03)00205-3 · DOI
  9. Salahshor, 1999, Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor, Br J Cancer, 81, 190, 10.1038/sj.bjc.6690676 · DOI
  10. Merok, 2012, Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series, Ann Oncol, 24, 1274, 10.1093/annonc/mds614 · DOI
  11. Nome, 2013, Common fusion transcripts identified in colorectal cancer cell lines by high-throughput RNA sequencing, Transl. Oncol, 6, 546, 10.1593/tlo.13457 · DOI
  12. Li, 2009, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform, Bioinformatics, 25, 1754, 10.1093/bioinformatics/btp324 · DOI · Paper page
  13. Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci Signal, 6, l1, 10.1126/scisignal.2004088 · DOI · Paper page
  14. Sirnes, 2012, Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome, Int J Cancer, 131, 570, 10.1002/ijc.26392 · DOI
  15. Bruun, 2014, Prognostic significance of beta-catenin, E-cadherin, and SOX9 in colorectal cancer: results from a large population-representative series, Front Oncol, 4, 118, 10.3389/fonc.2014.00118 · DOI
  16. Punt, 2007, Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials, J Natl Cancer Inst, 99, 998, 10.1093/jnci/djm024 · DOI
  17. de la Pena, 2009, Three-way RNA junctions with remote tertiary contacts: a recurrent and highly versatile fold, RNA, 15, 1949, 10.1261/rna.1889509 · DOI
  18. Suraweera, 2001, Conservation of mononucleotide repeats within 3′ and 5′ untranslated regions and their instability in MSI-H colorectal cancer, Oncogene, 20, 7472, 10.1038/sj.onc.1204952 · DOI
  19. Hughes, 2006, Regulation of gene expression by alternative untranslated regions, Trends Genet, 22, 119, 10.1016/j.tig.2006.01.001 · DOI
  20. Pickering, 2005, The implications of structured 5′ untranslated regions on translation and disease, Semin Cell Dev Biol, 16, 39, 10.1016/j.semcdb.2004.11.006 · DOI · Paper page
  21. Matsuo, 2013, MiR-29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2, Mol Cancer, 12, 15, 10.1186/1476-4598-12-15 · DOI
  22. McFarland, 2013, Impact of deleterious passenger mutations on cancer progression, Proc Natl Acad Sci U S A, 110, 2910, 10.1073/pnas.1213968110 · DOI
  23. McFarland, 2014, Tug-of-war between driver and passenger mutations in cancer and other adaptive processes, Proc Natl Acad Sci U S A, 111, 15138, 10.1073/pnas.1404341111 · DOI
  24. Sinicrope, 2011, DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy, J Natl Cancer Inst, 103, 863, 10.1093/jnci/djr153 · DOI
  25. Lothe, 1995, Deletion of 1p loci and microsatellite instability in colorectal polyps, Genes Chromosomes Cancer, 14, 182, 10.1002/gcc.2870140305 · DOI
  26. Thorstensen, 2000, Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients, Neoplasia, 2, 514, 10.1038/sj.neo.7900111 · DOI
  27. Grady, 2008, Genomic and epigenetic instability in colorectal cancer pathogenesis, Gastroenterology, 135, 1079, 10.1053/j.gastro.2008.07.076 · DOI
  28. Williamson, 2014, Coronin-1C and RCC2 guide mesenchymal migration by trafficking Rac1 and controlling GEF exposure, J Cell Sci, 127, 4292
  29. Grigera, 2012, Mass spectrometric analysis identifies a cortactin-RCC2/TD60 interaction in mitotic cells, J Proteomics, 75, 2153, 10.1016/j.jprot.2012.01.012 · DOI
  30. Kirkbride, 2011, Cortactin: a multifunctional regulator of cellular invasiveness, Cell Adh Migr, 5, 187, 10.4161/cam.5.2.14773 · DOI
  31. Byron, 2011, Proteomic analysis of integrin adhesion complexes, Sci Signal, 4, t2, 10.1126/scisignal.2001896 · DOI

Metadata

Authors
Bruun, J., Kolberg, M., Ahlquist, T. C., Røyrvik, E. C., Nome, T., Leithe, E., Lind, G. E., Merok, M. A., Rognum, T. O., Bjørkøy, G., Johansen, T., Lindblom, A., Sun, X.-F., Svindland, A., Liestøl, K., Nesbakken, A., Skotheim, R. I., & Lothe, R. A.
Affiliations
  • Oslo University Hospital (NO)
  • Norwegian Institute of Public Health (NO)
  • 9University College of Sør-Trøndelag, Trondheim, Norway.
  • UiT The Arctic University of Norway (NO)
  • Karolinska Institutet (SE)
  • Linköping University (SE)
  • University of Oslo (NO)
Corresponding author
Lothe, Ragnhild A.
Venue
Clinical Cancer Research
Published
2015-08-13
Volume
21
Issue
16
Pages
3759-3770
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2119853462
Cited by
41
References
2
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 5 · 2020: 7 · 2019: 4 · 2018: 7 · 2017: 4 · 2016: 2
FWCI
3.43
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • DiVA (Linkoping University) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
Keywords
RCC2, colorectal cancer, microsatellite instability, microsatellite stable tumors, prognostic factors, cell cycle regulation, apoptosis, cell proliferation, rectal cancer, high-risk patient stratification
MeSH terms
Age Factors, Aged, Aged, 80 and over, Chromosomal Proteins, Non-Histone, Chromosomes, DNA Mutational Analysis, Female, Humans, Male, Middle Aged, Neoplasm Staging, Prognosis, Biomarkers, Tumor, Colorectal Neoplasms, Disease-Free Survival, Guanine Nucleotide Exchange Factors, Cell Line, Tumor, Microsatellite Instability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review